Alps Advisors Inc Pharvaris N.V. Transaction History
Alps Advisors Inc
- $17.2 Billion
- Q2 2025
A detailed history of Alps Advisors Inc transactions in Pharvaris N.V. stock. As of the latest transaction made, Alps Advisors Inc holds 29,398 shares of PHVS stock, worth $694,674. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,398
Previous 36,633
19.75%
Holding current value
$694,674
Previous $575,000
10.09%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PHVS
# of Institutions
58Shares Held
39.2MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$178 Million4.61% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.41MShares$104 Million85.48% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$101 Million79.45% of portfolio
-
Viking Global Investors LP3.65MShares$86.3 Million0.2% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$78.1 Million17.44% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $798M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...